Annapolis-based PharmAthene, Inc. and N.Y.-based SIGA Technologies Inc. ? two biotech companies ? announced Friday that they have signed a definitive merger agreement creating a new company called PharmAthene.
The companies said they plan to be leaders in “bio-defense products targeting anthrax, smallpox and chemical nerve agents.”
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.